Keynote and plenary speakers


Rajendra APTE
Keynote Lecture 1

Dr. Rajendra S. Apte is the Paul A. Cibis Distinguished Professor of Ophthalmology, Developmental Biology and Medicine at Washington University in St. Louis School of Medicine, where he also serves as the Director of Translational Research and Jeffrey Fort Innovation Fund. Dr. Apte joined Washington University after obtaining a Ph.D. in Immunology at the University of Texas Southwestern Medical Center in Dallas, Texas, and post completion of a fellowship in vitreo-retinal Surgery at The Johns Hopkins University.  Dr. Apte was then recruited to Washington University in 2003 and became a tenured professor at the School of Medicine in less than ten years. His basic research is focused on the broad areas of inflammation, angiogenesis and neurodegeneration and aging. His clinical interests include understanding the pathobiology of medical and surgical retinal diseases. Dr. Apte has published extensively in basic and clinical peer reviewed journals and has participated as a principal investigator in a number of clinical trials.

Read more.



Leonard LEVIN
Keynote Lecture 2

Leonard A. Levin, MD, PhD is Chair of the Department of Ophthalmology, McGill University. He did his undergraduate, graduate, and medical training at Harvard, and then pursued an ophthalmology residency and neuro-ophthalmology fellowship at the Massachusetts Eye and Ear Infirmary. He currently chairs the Executive Scientific Oversight Committee for the Audacious Goals Initiative at the USA National Eye Institute and the Association of Canadian University Professors of Ophthalmology. He is past chair of the Diseases and Pathophysiology of the Visual System study section at the United States National Institutes of Health. Dr. Levin has published more than 170 peer-reviewed papers, reviews, and book chapters, and has 4 issued patents. He has edited five textbooks in ophthalmology or neuro-ophthalmology, including Ocular Disease: Mechanisms and Management and the 11th edition of Adler’s Physiology of the EyeDr. Levin’s basic research is devoted to understanding how diseases of the optic nerve result in loss of connections between the eye and the brain, and finding was to prevent and reverse that damage. He also is interested in the challenges associated with successfully translating basic science research into clinically effective therapies, particularly for optic nerve disorders, and has been involved with the design and assessment of clinical trials to study neuroprotective therapies in glaucoma and other optic neuropathies.



Christine CURCIO
Keynote Lecture 3

Dr Curcio focuses on aging and age-related macular degeneration (AMD), the third largest cause of vision loss worldwide. Publications have included retinal cell biology, lipoprotein biology, clinical image validation, neurodegeneration, epidemiology, and transcriptomics. She has partnered for 25 years with the Alabama Eye Bank, a large eye bank and industry leader in rapid tissue recovery for research. Key findings include demonstrating that rod photoreceptors die before cones in aging and AMD and discovering and characterizing lipoproteins of ocular origin that constitute the main pathway of soft drusen, AMD’s pathognomonic lesions. 

Read more.



EVER-Acta Lecture

Prof Soubrane is professor of Ophthalmology in Hôtel-Dieu Hospital, Paris, France.  Emeritus Professor of the Department of Ophthalmology at the Eye University of Créteil – Université Paris Est Creteil XII. Her research focuses on improvements in the diagnosis of AMD, pathogenesis and experimental models of AMD. Her department has participated in the evaluation of all new therapeutic approaches and pharmacological interventions for CNV, while her achievements have included describing occult CNV and identifying the reticular pseudo drusen and chorioretinal anastomosis. Gisèle Soubrane has served as General Secretary of the French Society of Ophthalmology, General Secretary and President of the European Board of Ophthalmology, and President and honorary member of the European Societies for Vision and Eye Research. 

Read more.


Andrew DICK
EVER Lecture - delivered by the Past President

Traditional the EVER lecture is given by the past-president. This year the EVER lecture will be given by Prof. Andrew Dick, Bristol, UK.
Professor Andrew Dick qualified in medicine also with a degree in Biochemistry (BSc (Hons)) from the University of London, and during his medical education he spent time as an MRC sponsored research associate in Biochemistry with Professor Coleman in Yale. Following training in internal medicine and MRCP he entered ophthalmology residency and obtained his postgraduate research degree, MD in Immunology in 1993 at the University of Aberdeen. He underwent an MRC Post Doctoral Travelling Fellowship to work with Jon Sedgwick at the Centenary Institute of Cancer Medicine and Cell Biology in Sydney Australia. His clinical expertise is in inflammatory disorders of the eye, which has resulted in several eminent awards globally. 

Read more.



Jean-Jacques DE LAEY
European Ophthalmic Heritage Lecture

Jean-Jacques De Laey, MD, PhD - Emeritus professor of ophthalmology of the University of Ghent, Belgium.
Currently curator of the Museum of the History of Medicine in Ghent.Subspecialty : medical retina.
Author or co-author of 6 books and over 270 articles in peer reviewed journals mainly on medical retina.
Pastpresident of EUPO (European Professors in Ophthalmology), of EBO (European Board of Ophthalmology), program secretary and chair of the retina section of EVER (European Vision and Eye Research) (1999-2004), member of the Board of the International Council of Ophthalmology (ICO) (1993-2014), General secretary of the ICO (2006-2012) and  later Vice-President of the ICO (2012-2014). 



M. Francesca CORDEIRO
Ophthalmic Research Lecture

Professor M Francesca Cordeiro, is a clinician-scientist, Chair of Ophthalmology Imperial College London, UCL Professor of Glaucoma and Retinal Neurodegeneration, Honorary Consultant Ophthalmologist/Research Lead and Director of Clinical Trials Unit at the Western Eye Hospital London. She qualified in medicine from St Bartholomew’s Hospital University of London and completed training in general and surgical ophthalmology at Moorfield’s Eye & St Thomas’ Hospitals in London in 2003, following her PhD at UCL in 1998. Her research, mainly funded through the Wellcome Trust, is focused on the molecular mechanisms involved in either the treatment or pathogenesis of retinal neurodegenerative diseases, including glaucoma, Alzheimer’s, Parkinson’s and diabetes. She has investigated novel and translational approaches to these problems, with a target of saving sight and reducing disability. 

Read more.